Aquaporin 1 Promoter Variants in Peritoneal Dialysis: Large Insights Into Ultrasmall Pores

Affiliations

¹ Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Nephrology, University of Toronto, Toronto, Ontario, Canada.
² Division of Nephrology and Hypertension, The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California.
³ Division of Nephrology, University of Toronto, Toronto, Ontario, Canada; Division of Nephrology, Department of Medicine, St. Michael's Hospital, Toronto, Ontario, Canada. Electronic address: jeff.perl@utoronto.ca.

Editorial

Zeenia Aga et al. Am J Kidney Dis. 2022 May.

. 2022 May;79(5):757-759.

doi: 10.1053/j.ajkd.2022.01.420. Epub 2022 Feb 4.

¹ Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Nephrology, University of Toronto, Toronto, Ontario, Canada.
² Division of Nephrology and Hypertension, The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California.
³ Division of Nephrology, University of Toronto, Toronto, Ontario, Canada; Division of Nephrology, Department of Medicine, St. Michael's Hospital, Toronto, Ontario, Canada. Electronic address: jeff.perl@utoronto.ca.

No abstract available

Comment on

AQP1 Promoter Variant, Water Transport, and Outcomes in Peritoneal Dialysis.
Morelle J, Marechal C, Yu Z, Debaix H, Corre T, Lambie M, Verduijn M, Dekker F, Bovy P, Evenepoel P, Bammens B, Selgas R, Bajo MA, Coester AM, Sow A, Hautem N, Struijk DG, Krediet RT, Balligand JL, Goffin E, Crott R, Ripoche P, Davies S, Devuyst O. Morelle J, et al. N Engl J Med. 2021 Oct 21;385(17):1570-1580. doi: 10.1056/NEJMoa2034279. N Engl J Med. 2021. PMID: 34670044